Carla Greenbaum, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D (NCT03632759) | Carla Greenbaum, MD | 2018-08-15 |
Track Carla Greenbaum, MD automatically
Every clearance here is in the API, with alerts when new ones post.